An amino acid substitution in a capsid protein enhances phage survival in mouse circulatory system more than a

Christal L Vitiello1, Carl R Merril, Sankar Adhya

  • 1Section of Developmental Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Virus Research
|August 2, 2005
PubMed

Insights

Researchers engineered a bacteriophage lambda mutant, lambdaArgo phage, to prolong its circulation time in mice. A single mutation in the E protein was identified as sufficient for this "long-circulating" phenotype, aiding innate immunity studies and phage therapy development.

Area of Science:

  • Virology
  • Immunology
  • Microbial Genetics

Background:

  • Bacteriophage lambda clearance in mice is rapid, with titers decreasing significantly within 48 hours.
  • Previous selection methods yielded
  • long-circulating
  • lambda phage (lambdaArgo phage) with multiple mutations, including one in the E protein.

Purpose of the Study:

  • To determine if a single mutation in the phage lambda E protein is sufficient to confer a
  • long-circulating
  • phenotype.
  • To develop an isogenic pair of phage for studying innate immune recognition and phage therapy.

Main Methods:

  • Site-directed mutagenesis to create an isogenic pair of phage lambda.
  • Comparison of circulation kinetics between wild-type and mutant phage in mice.
  • Characterization of the E protein substitution (glutamic acid to lysine at residue 158).

Main Results:

  • A single amino acid substitution (E protein, residue 158) is sufficient to confer the
  • long-circulating
  • phenotype.
  • The engineered phage exhibited significantly prolonged circulation times compared to wild-type phage.
  • An isogenic pair of phage was successfully created.

Conclusions:

  • The specific E protein mutation is a key driver of prolonged phage circulation.
  • This research provides a valuable tool for investigating innate immune responses to viruses.
  • The findings support the development of enhanced bacteriophage strains for therapeutic applications against bacterial infections.

Related Concept Videos

DNA Bacteriophages01:26

DNA Bacteriophages

Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
Lytic Cycle of Bacteriophages01:30

Lytic Cycle of Bacteriophages

Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the lytic replication...
Bacteriophages of the Human Virome01:23

Bacteriophages of the Human Virome

Bacteriophages are found throughout the human body. They may even outnumber eukaryotic viruses, forming an important and dynamic component of the human virome. Indeed, phages represent the most abundant viral entities, with densities in the gut reaching up to 10⁹ particles per gram of fecal matter, and many belonging to orders such as Caudovirales and Microviridae, while a substantial proportion remains unclassified as viral “dark matter.”Lysogeny and Genetic ExchangeIn the gut, bacteriophages...